GUGGENHIME ANDREW bought PCVX
August 3, 2026 · Form 4 insider transaction
GUGGENHIME ANDREW bought 10,000 shares of Vaxcyte, Inc. at $5.35 per share, a transaction worth $53.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$5.35
Total value
$53.5K
InsiderGUGGENHIME ANDREW
Role—
CompanyVaxcyte, Inc. (PCVX)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 3, 2026
Filing dateAugust 5, 2026
Shares owned after115,176
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.